Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

The Efficacy and Safety of Homoharringtonine Added to Venetoclax and Azacitidine in the Frontline Treatment of Newly Diagnosed Acute Myeloid Leukemia, a Multi-Center Exploratory Cohort Study

Guopan Yu, Zurong Yao, Zhao Yin, Yu Zhang, Weihua Zhao, Guangyang Weng, Ziwen Guo, Zhiqiang Sun, Pengcheng Shi, Xuejie Jiang, Dan Xu, Li Xuan, Qifa Liu

Blood (2024) 144 (Supplement 1): 4283.

https://doi.org/10.1182/blood-2024-206872

Published: 2024

Journal Articles

Poor Response of Venetoclax/Azacitidine in Monocytic-like Acute Myeloid Leukemia Might be Associated with Genetic Patterns and Could be Improved By Addition of Homoharringtonine

Guopan Yu, Yishan Chen, Zhao Yin, Yu Zhang, Weihua Zhao, Guangyang Weng, Xin Du, Danian Nie, Ziwen Guo, Zhiqiang Sun, Hongyu Zhang, Dongjun Lin, Xinquan Liang, Pengcheng Shi, Xuejie Jiang, Dan Xu, Li Xuan, Baohong Ping, Qifa Liu

Blood (2024) 144 (Supplement 1): 1516.

https://doi.org/10.1182/blood-2024-201974

Published: 2024

Journal Articles

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 4274.

https://doi.org/10.1182/blood-2023-182832

Published: 2023

Journal Articles

Homoharringtonine Overcomes the Negative Impact of Genetic Patterns on Venetoclax Plus Azacitidine Regimen in Relapsed/Refractory Acute Myeloid Leukemia: A Multi-Center, Cohort Study

Guopan Yu, Yu Zhang, Hua Jin, Zhao Yin, Guangyang Weng, Sijian Yu, Na Xu, Xin Du, Dongjun Lin, Jie Xiao, Zhiqiang Sun, Hongyu Zhang, Xinquan Liang, Ziwen Guo, Weihua Zhao, Min Dai, Xuejie Jiang, Li Xuan, Pengcheng Shi

Blood (2023) 142 (Supplement 1): 4262.

https://doi.org/10.1182/blood-2023-182847

Published: 2023

Journal Articles

Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Fen Huang, Jing Du, Pinjing Lv, Kaibo Yang, Zhiping Fan, Li Xuan, Jing Sun, Na Xu, Hui Liu, Pengcheng Shi, Xiaofang LI, Jun Xu, Zhixiang Wang, Pu Wang, Xiang Yao, Ye Chen, Qifa Liu

Blood (2023) 142 (Supplement 1): 3569.

https://doi.org/10.1182/blood-2023-179098

Published: 2023

Journal Articles

The Efficacy and Safety of CLAG±Ida/Mito+Ven As Salvage Therapy of Relapsed/Refractory Acute Myeloid Leukemia

Guopan Yu, Zhao Yin, Yu Zhang, Xuejie Jiang, Xiaqi Nie, Zurong Yao, Dan Xu, Pengcheng Shi

Blood (2023) 142 (Supplement 1): 5909.

https://doi.org/10.1182/blood-2023-184772

Published: 2023

Journal Articles

The Dynamic Evolution of Bone Marrow Adipocytes during Acute Lymphoblastic Leukemia Pathogenesis and Therapy

Xi Jia, Naying Liao, Xinyuan Chen, Yunqian Yao, Kai Chen, Pengcheng Shi

Blood (2022) 140 (Supplement 1): 11525.

https://doi.org/10.1182/blood-2022-166276

Published: 2022

Journal Articles

Efficacy of Mesenchymal Stromal Cells for Refractory Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

Ke Zhao, Zhiping Fan, Xiaoyong Chen, Yuan Chang, Li Xuan, Na Xu, Fen Huang, Pengcheng Shi, Ren Lin, Hui Liu, Jing Sun, Andy Peng Xiang, Qifa Liu

Blood (2022) 140 (Supplement 1): 12746.

https://doi.org/10.1182/blood-2022-159956

Published: 2022

Journal Articles

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 3292–3293.

https://doi.org/10.1182/blood-2022-165261

Published: 2022

Journal Articles

Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Blood (2022) 140 (Supplement 1): 2392.

https://doi.org/10.1182/blood-2022-158688

Published: 2022

Journal Articles

Prospective Evaluation of Sorafenib Combined with Chemotherapy in Newly Diagnosed Adult Core-Binding Factor Acute Myeloid Leukemia: An Open-Label, Randomized Controlled, Multicenter Phase II Trial

Pengcheng Shi, Xi Jia, Naying Liao, Yin Changxin, Huan Li, Xuejie Jiang, Guopan Yu, Jieyu Ye, Hong Qu, Yu Zhan, Chunju Wen, Yu Zhang, Qifa Liu

Blood (2022) 140 (Supplement 1): 2005–2006.

https://doi.org/10.1182/blood-2022-156348

Published: 2022

Journal Articles

The Impact of CD19 Expression Combined with Measurable Residual Disease on Post-Remission Treatment and Outcome in Adult t(8;21) Acute Myeloid Leukemia

Pengcheng Shi, Naying Liao, Ning Wu, Huan Li, Fen Huang, Na Xu, Zhiping Fan, Yu Zhang, Qifa Liu

Blood (2021) 138 (Supplement 1): 4445.

https://doi.org/10.1182/blood-2021-149407

Published: 2021

Journal Articles

Retrospective Analysis of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation

Yingyao Chen, Jun Xu, Zhiping Fan, Na Xu, Fen Huang, Pengcheng Shi, Qifa Liu, Jing Sun

Blood (2021) 138 (Supplement 1): 4877.

https://doi.org/10.1182/blood-2021-150602

Published: 2021

Journal Articles

Cidofovir, a Choice for Salvage Treatment of CMV Infection in the Patients with Haploidentical Hematopoitic Stem Cell Transplantation

Zhao Yin, Na Xu, Ling Jiang, Pengcheng Shi, Zhiping Fan, MD, Fen Huang, Qifa Liu, MD, Jing Sun, Guopan Yu

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-138685

Published: 2020

Journal Articles

Combination of Homoharringtonine with Venetoclax and Azacitidine Excerts Better Treatment Response in Relapsed /Refractory Acute Myeloid Leukemia

Guopan Yu, Na Xu, Fen Huang, Zhiping Fan, MD, Hui Liu, Pengcheng Shi, Hongsheng Zhou, MD PhD, Zhixiang Wang, Yu Zhang, Qifa Liu, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-138676

Published: 2020

Journal Articles

Efficacy and Safety of Ruxolitinib in Treatment of Steroid Refractory/Refractory Acute Graft-Versus-Host Disease: A Prospective Multicenter Research

Zhiping Fan, MD, Lan Deng, MD PhD, Xudong Li, Qing Zhang, MD, Li Xuan, Fen Huang, Ren Lin, Hua Jin, Na Xu, PhD, Pengcheng Shi, Zhixiang Wang, PhD, Jieyu Ye, Ling Jiang, Jing Sun, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 5724.

https://doi.org/10.1182/blood-2018-99-117430

Published: 2018

Journal Articles

Hematologic Malignancies and Carbapenem Resistance: A Multicentre Retrospective Study from Chinese People

Bing Xu, MD PhD, Suming Huang, PhD, Lingli He, Guoshu Chen, Zhifeng Li, Pengcheng Shi, Xutao Guo, Zhihong Fang, Yan Wang, Jie Li, Yong Zhou

Blood (2017) 130 (Supplement 1): 4826.

https://doi.org/10.1182/blood.V130.Suppl_1.4826.4826

Published: 2017

Journal Articles

Detection of miR3151 Gene Expression in De Novo Adult Acute Myeloid Leukemia and Its Clinical Implication

Guo Xutao, PhD, Yan Wang, Pengcheng Shi, Suqi Deng, Haiqing Zheng, Ru Feng, MD, Bing Xu, MD PhD

Blood (2017) 130 (Supplement 1): 5076.

https://doi.org/10.1182/blood.V130.Suppl_1.5076.5076

Published: 2017

Journal Articles

Tigecycline Was a Promising Candidate for Febrile Neutropenic and Carbapenem-Resistant Patients with Hematologic Malignancy

Bing Xu, PhD, Lingli He, Pengcheng Shi, Xutao Guo, Jie Li, Yan Wang, Manman Deng, Yong Zhou, Yin Li, Jiabao Liang

Blood (2015) 126 (23): 4610.

https://doi.org/10.1182/blood.V126.23.4610.4610

Published: 2015

Journal Articles

Prophylactic Use of Sorafenib in Patients with FLT3-ITD-Positive Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Qifa Liu, MD, Li Xuan, Zhiping Fan, Qianli Jiang, Min Dai, Pengcheng Shi, MD, Changxin Yin, MD, Jing Sun, MD

Blood (2014) 124 (21): 3943.

https://doi.org/10.1182/blood.V124.21.3943.3943

Published: 2014

NARROW

The Efficacy and Safety of Homoharringtonine Added to Venetoclax and Azacitidine in the Frontline Treatment of Newly Diagnosed Acute Myeloid Leukemia, a Multi-Center Exploratory Cohort Study

Poor Response of Venetoclax/Azacitidine in Monocytic-like Acute Myeloid Leukemia Might be Associated with Genetic Patterns and Could be Improved By Addition of Homoharringtonine

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Homoharringtonine Overcomes the Negative Impact of Genetic Patterns on Venetoclax Plus Azacitidine Regimen in Relapsed/Refractory Acute Myeloid Leukemia: A Multi-Center, Cohort Study

Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

The Efficacy and Safety of CLAG±Ida/Mito+Ven As Salvage Therapy of Relapsed/Refractory Acute Myeloid Leukemia

The Dynamic Evolution of Bone Marrow Adipocytes during Acute Lymphoblastic Leukemia Pathogenesis and Therapy

Efficacy of Mesenchymal Stromal Cells for Refractory Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Prospective Evaluation of Sorafenib Combined with Chemotherapy in Newly Diagnosed Adult Core-Binding Factor Acute Myeloid Leukemia: An Open-Label, Randomized Controlled, Multicenter Phase II Trial

The Impact of CD19 Expression Combined with Measurable Residual Disease on Post-Remission Treatment and Outcome in Adult t(8;21) Acute Myeloid Leukemia

Retrospective Analysis of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation

Cidofovir, a Choice for Salvage Treatment of CMV Infection in the Patients with Haploidentical Hematopoitic Stem Cell Transplantation

Combination of Homoharringtonine with Venetoclax and Azacitidine Excerts Better Treatment Response in Relapsed /Refractory Acute Myeloid Leukemia

Efficacy and Safety of Ruxolitinib in Treatment of Steroid Refractory/Refractory Acute Graft-Versus-Host Disease: A Prospective Multicenter Research

Hematologic Malignancies and Carbapenem Resistance: A Multicentre Retrospective Study from Chinese People

Detection of miR3151 Gene Expression in De Novo Adult Acute Myeloid Leukemia and Its Clinical Implication

Tigecycline Was a Promising Candidate for Febrile Neutropenic and Carbapenem-Resistant Patients with Hematologic Malignancy

Prophylactic Use of Sorafenib in Patients with FLT3-ITD-Positive Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only